Search

everythinglearnresearchcommunity

for

Search:↓

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Cetuximab can cause eyelash growth, which is rare but manageable.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Panitumumab can cause excessive ear hair growth.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.